Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)
Ratios

Black Diamond Therapeutics (BDTX) Leases (2020 - 2025)

Black Diamond Therapeutics (BDTX) has disclosed Leases for 2 consecutive years, with $28.4 million as the latest value for Q3 2021.

  • For the quarter ending Q3 2021, Leases rose 235.16% year-over-year to $28.4 million, compared with a TTM value of $28.4 million through Sep 2021, up 235.16%, and an annual FY2020 reading of $8.4 million, changed N/A over the prior year.
  • Leases was $28.4 million for Q3 2021 at Black Diamond Therapeutics, up from $13.2 million in the prior quarter.
  • Across five years, Leases topped out at $28.4 million in Q3 2021 and bottomed at $382000.0 in Q2 2020.